ILUVIEN®

1 Intravitreal implant in applicator. Generic name: Fluocinolone acetonide.

Interested

Indication:

For the treatment of diabetic macular edema in patients who have been treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.

For prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye.

Iluvien® has a manageable and known safety profile.

Benefits:

Iluvien is an innovative technology for a continuous and stable release of steroids for up to 3 years.

It is a micro-implant specifically designed to provide long-acting, sustained release of the lowest dose of active ingredient.

Provides continuous micro dosing for up to 3 years.

Provides sustained improvement in visual acuity for up to 3 years ILUVIEN® can deliver rapid and sustained drying of the macula for up to three years.

Reduces treatment burden for the patient.

Provides the freedom from the burden of multiple injections.

No Brochures uploaded for this product.